# Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

> **NCT00099749** · PHASE2,PHASE3 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 255 (—)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** FTY 720

## Key facts

- **NCT ID:** NCT00099749
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-11
- **Primary completion:** 2006-04
- **Final completion:** —
- **Target enrollment:** 255 (—)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00099749

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00099749, "Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00099749. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*